Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1 Completed 1

Sponsor Class

INDUSTRY 10 OTHER 8 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Melanoma 3 Leukemia, Myeloid, Acute 3 Carcinoma, Non-Small-Cell Lung 3 Sarcoma, Kaposi 2 Sarcoma, Alveolar Soft Part 2 Prostatic Neoplasms 2 Non-Muscle Invasive Bladder Neoplasms 2 Lymphoma 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Urinary Incontinence 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Solid Tumor 1 Skin Neoplasms 1 Sarcoma, Synovial 1 Sarcoma, Clear Cell 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Neurofibrosarcoma 1 Neoplasms 1 Musculoskeletal Pain 1 Multiple Myeloma 1 Malignant Solid Neoplasm 1 Lymphoma, Non-Hodgkin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × NETWORK × Solid Tumor × Clear all

NCT06524024 2025-02-10

DC-CTL

Zhengzhou Revo-Gene Technology Co., LTD

Phase NA Not yet recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡